Publication de Nicole Delepine : Variations of the induction effect of Ifosfamide in 7 children during of 5 days continuous infusion over 4 treatment sessions.

Nicole delépine, le site officiel English Version Version Française
Accueil Site officiel ACCUEIL
Accueil du site officiel de Nicole Delepine
publication cancérologue réputé nicole delepine ostéosarcome
sarcome ewing publications du docteur nicole delepine
Publié sur : Journal of Clinical Oncology. Volume 19 ; 20-23 ; page 216a Abstract N° 843 - 2000
Voir la version PDF de cette publication : Document PDF | Publication sur le site du média : Document www
Variations of the induction effect of Ifosfamide in 7 children during of 5 days continuous infusion over 4 treatment sessions.
B. Gourmel, S. Denis, Nicole Delepine

Variation of the Induction Effect of Ifosfamide in 7 Children During a 5 Day Continuous Infusion Over 4 Treatment Sessions.


Developmental Therapeutics / Developmental Therapeutics - Clinical Pharmacology and Immunotherapy


Abstract:


7 patients (6 - 21 yr.) suffering from bone and soft tissue sarcoma, were followed over 4 months, during their 5-day treatment (tt) session by ifosfamide (If.) 3g/m2/day.
We estimate the variations of If., and its metabolites 2 d-If., 3 d-If. and mainly 4 OH-If. using a GC/NPD technic2. Pharmacokinetic analysis was performed to estimate daily AUC for each compound during each tt session. The percentage of induction (PI) for If. was defined as Conc.24 / Cone.120 & daily metabolite index (MI) as AUC metabolite/AUC If.
The 4 tt session profiles of If. showed a similar shape: levels raised to a Cmax reached at the end of day 1, & then regularly decreased to reach a steady state, on day 5. The PI were respectively: 33.6%|20.2, 41.9%|18.4, 48.0%|33.4 and 48.9%|31.2.
No statistical significant difference (t test) was shown between sessions 1 to 4 either for the blood levels niether for the PI. The daily MI for inactive metabolites showed a continuous increase during the infusion duration over each tt sessions.
For 2d-If., the last day MI were 18.5%|18.7, 18.0%|10.2, 17.3%|9.9 and 16.8%| 9.8 and for 3d-If. 22.9%|5.0, 21.8%|5.8, 21.0%|7.9 and 19.8%|6.3 (not significantly different: t test).
The active metabolite 4OH If. blood levels remained low during the entire infusion. The MI increase of 4OH-If. during the infusion was observed for any of the studied tt sessions. 4OH-If. last day MI were respectively 2.3%|0.8, 2.0%|0.6, 2.1%|0.5 and 1.8%|0.5 for the different sessions, (not significantly different, whatever tt session considered). Such regimen confirmed a relevant induction phenomenon in children during the 4 sessions. Each MI increase during the duration of the infusion, was mainly due to a decrease of the If. rather than a relevant increase of the metabolites blood levels.
For 4OH-If., a more significative blood level increase was noted. Therefore, the global induction process remains especially favorable for the 4OH-If. pathways. These data did not permit to demonstrate a statistical significative difference for the different sessions. (Supported by a "Ligue nationale Paris" grant N|98/RS-PH/86). 2Gourmel & al. J. Chromatogr B. 1999; 732 (1) :3-15.




publications médicales


sarcome d'ewing
nicole delepine cancer tumeur ostéosarcome
Facebook Tweeter Google+